Navigation Links
Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology

Advanced Artificial Intelligence Software Is Cost-Effective, Time-Saving

ATLANTA, Oct. 1 /PRNewswire/ -- Harmonex Corporation today announced the formal launch of CliniCom(TM), a revolutionary software platform designed to assess children, adolescents and adults for possible psychiatric conditions.

CliniCom(TM), an intuitive, computer assisted intake and assessment tool created for use in mental health settings, gathers information directly from patients and their advocates prior to an initial evaluation. Designed to elevate the level of patient care, this technology also offers physicians a highly accurate, time-saving complement to their in-office care.

"We are very pleased to offer this unique technology to our colleagues after many years of rigorous research and development," said Nelson M. Handal, M.D., Harmonex's chairman and medical director. "Thanks to CliniCom(TM), higher quality care, better use of clinical time, a more thorough patient experience, and more robust clinical research is not only possible, but is already a reality at all CliniCom(TM) sites."

Dr. Handal, a practicing board certified child, adolescent, and adult psychiatrist, developed CliniCom(TM) together with Harmonex's team of physicians, technologists, researchers, health care and global software experts after identifying a pervasive and critical need for accurate data in the mental health field. This technology enables doctors and patients across the network -- which includes private practices, hospitals, and other front line care providers -- to also participate in clinical research initiatives on a scale never seen before in mental health.

"One compelling aspect of this exciting new technology is that doctors require only an Internet connection and computer to reap the benefits of CliniCom(TM) -- with no upfront or licensing fees," said Sharon Allred, chief executive officer. "By helping doctors to reach the correct assessment the first time, CliniCom(TM) makes better use of in-office time and reduces the risk of an inaccurate medical diagnosis."

CliniCom(TM) is also reimbursable by major insurance companies, which in turn helps contribute to the sites' bottom line. Psychiatrists are among the lowest paid physicians and quality resources such as technology are often too expensive or out of reach. CliniCom(TM) makes it easy and cost effective for doctors to upgrade their quality of care and significantly improve the overall patient experience.

Patients interact with the technology on their own before meeting with the doctor. This means that doctors can spend the limited time previously available for assessing patients to build better rapport, educate patients and refine a treatment plan. A recent independent survey of over 400 CliniCom(TM) users found that 92% of those surveyed reported that CliniCom(TM) was very easy to use.

IISY, a leading global software development company specializing in knowledge base management and artificial intelligence based software tools, developed the core software platform which provides unprecedented flexibility and application stability within CliniCom(TM). IISY's global client portfolio includes Daimler-Benz, Deutsche Telecom, Drager Medical, Siemens, Swiss Com and T-Mobile.

On the policy front, the U.S. government has long recognized the importance of modernizing the fragmented and complex mental health sector. In 2003, President George Bush inaugurated the President's New Freedom Commission on Mental Health with the goal of eliminating disparities in mental health care and promoting technology to improve the mental health care system. In addition, several members of Congress have recently introduced health IT bills incentivizing doctors, hospitals and insurance companies to adopt IT programs, including the development of electronic mental health records.

Harmonex is a privately held bio-technology and clinical research organization committed to providing mental health professionals with tools and resources that help address key issues in assessing and treating patients for mental illness. With primary sites in Atlanta, Georgia and Dothan, Alabama, Harmonex's objective is to provide patients with access to the highest quality of care possible. For more information, videos, and other resources, please visit the website at You may also visit Harmonex's booth (number 413) at the 54th annual meeting of the American Academy of Child & Adolescent Psychiatry in Boston, MA, October 23rd-27th.

Contact Information:

G. William Handal

Chief Operating Officer & Marketing Director


SOURCE Harmonex Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GE Healthcare introduces MR imaging product
2. Online fishing site introduces interactive maps
3. GE introduces remotely hosted health services
4. Norlight introduces new e-mail security service
5. Angel network introduces ePlan
6. RedPrairie Corp. introduces new supply chain software
7. GE introduces compact ultrasound system for women
8. MailFoundry introduces new e-mail archive product
9. Madison biotech introduces drug discovery advance
10. Alfalight introduces new 25-watt pump module
11. Wisconsin introduces new state IT plan
Post Your Comments:
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):